2014
DOI: 10.1016/j.jcpa.2013.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Lymphangiogenesis in Canine Mammary Tumours: A Morphometric and Prognostic Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 58 publications
0
4
0
Order By: Relevance
“…; Sleeckx et al . ). In addition, the upregulation of VEGFR‐2 was also observed in canine SCC Al‐Dissi et al .…”
Section: Introductionmentioning
confidence: 97%
See 1 more Smart Citation
“…; Sleeckx et al . ). In addition, the upregulation of VEGFR‐2 was also observed in canine SCC Al‐Dissi et al .…”
Section: Introductionmentioning
confidence: 97%
“…However, although several studies have reported on the expression of angiogenesisrelated genes in canine tumours, few studies have compared the expression profiles of angiogenesisrelated genes in normal and tumour tissues. It was reported that the expression of VEGF-A was correlated with malignant progression of canine squamous cell carcinomas (SCC) and seminomas (Al-Dissi et al 2007;Sleeckx et al 2014). In addition, the upregulation of VEGFR-2 was also observed in canine SCC Al-Dissi et al 2007.…”
Section: Introductionmentioning
confidence: 99%
“…2024, 11, 238 2 of 23 resistance [12,13]. Furthermore, CMTs have been suggested as a model to study the pathogenesis and prognosis of HBC [14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…Notably, CMTs and human breast cancer (HBC) share a significant number of similarities in pathogenic factors, histological characteristics, molecular phenotypes, biological behaviors, and modes of metastasis [ 10 , 11 ], such as acquired chemotherapeutic resistance [ 12 , 13 ]. Furthermore, CMTs have been suggested as a model to study the pathogenesis and prognosis of HBC [ 14 , 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%